{"id":17753,"date":"2026-02-03T19:54:19","date_gmt":"2026-02-03T19:54:19","guid":{"rendered":"https:\/\/diyhaven858.wasmer.app\/index.php\/novo-nordisk-sees-lower-sales-profits-as-wegovy-faces-growing-competition\/"},"modified":"2026-02-03T19:54:19","modified_gmt":"2026-02-03T19:54:19","slug":"novo-nordisk-sees-lower-sales-profits-as-wegovy-faces-growing-competition","status":"publish","type":"post","link":"https:\/\/diyhaven858.wasmer.app\/index.php\/novo-nordisk-sees-lower-sales-profits-as-wegovy-faces-growing-competition\/","title":{"rendered":"Novo Nordisk sees lower sales, profits as Wegovy faces growing competition"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div>\n<p>Novo Nordisk on Tuesday said it expects sales and profits to decline this year, as the maker of Wegovy faces growing competition in the obesity market.<\/p>\n<p>The Danish pharma giant said it expects sales to decrease in the range of 5% to 13% in 2026, more than the 3% decrease forecasted by analysts surveyed by Visible Alpha. Novo also expects operating profits to decrease in the range of 5% to 13%, while analysts predicted a 5% decrease.<\/p>\n<aside class=\"alignleft wp-block-stat-article-recirc-single\">\n<div class=\"recirc-single-image\" data-href=\"https:\/\/www.statnews.com\/2025\/12\/29\/wegovy-pill-price-novo-nordisk-strategy-weight-loss-drugs\/\">\n\t\t\t<img decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2025\/12\/NOVO_PILL_01-768x432.jpg\" class=\"attachment-article-main-medium-large size-article-main-medium-large\" alt=\"\" loading=\"lazy\" sizes=\"auto, (min-width: 540px) and (max-width: 767px) 288px, (min-width: 768px) and (max-width: 1023px) 257px, (min-width: 1024px) and (max-width: 1199px) 287px, (min-width: 1200px) 245px, 246px\" srcset=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2025\/12\/NOVO_PILL_01-768x432.jpg 768w, https:\/\/www.statnews.com\/wp-content\/uploads\/2025\/12\/NOVO_PILL_01-328x185.jpg 328w, https:\/\/www.statnews.com\/wp-content\/uploads\/2025\/12\/NOVO_PILL_01-1024x576.jpg 1024w, https:\/\/www.statnews.com\/wp-content\/uploads\/2025\/12\/NOVO_PILL_01-500x281.jpg 500w, https:\/\/www.statnews.com\/wp-content\/uploads\/2025\/12\/NOVO_PILL_01-1600x900.jpg 1600w, https:\/\/www.statnews.com\/wp-content\/uploads\/2025\/12\/NOVO_PILL_01-640x360.jpg 640w, https:\/\/www.statnews.com\/wp-content\/uploads\/2025\/12\/NOVO_PILL_01.jpg 1920w\"\/>\t\t<\/div>\n<h3 class=\"recirc-single-heading\">\n<div class=\"stat-plus-icon\" data-tooltip=\"Subscriber-only\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/home\/statplus.svg\" width=\"19\" height=\"16\" alt=\"\"\/><\/div>\n<p>\t\t\t\t<span class=\"sr-only\">STAT Plus: <\/span>With the Wegovy pill, Novo Nordisk undercuts Eli Lilly in direct-to-consumer market<br \/>\n\t\t<\/h3>\n<\/aside>\n<p>Shares of Novo plummeted more than 14% as of midday Tuesday. The company was scheduled to report earnings on Wednesday, but released these results early.<\/p>\n<div class=\"restricted-content-breaker article\" aria-labelledby=\"restricted-story-heading\" aria-describedby=\"restricted-story-description\" checked=\"false\">\n<div class=\"restricted-content-breaker-bar\">\n<p class=\"restricted-text\">STAT+ Exclusive Story<\/p>\n<p class=\"restricted-login\">Already have an account? Log in<\/p>\n<\/p><\/div>\n<p>\t\t\t<img decoding=\"async\" class=\"restricted-content-breaker-bg\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-breaker-bg.png\" alt=\"STAT+\"\/><\/p>\n<div class=\"restricted-content-breaker-wrapper\">\n\t\t\t\t<span class=\"stat-paywall-archive\"><\/p>\n<p>\t\t\t\t\t\t<img decoding=\"async\" class=\"stat-plus-logo\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\" alt=\"STAT+\"\/><\/p>\n<p>\t\t\t\t<\/span><\/p>\n<h2 id=\"restricted-story-heading\">This article is exclusive to STAT+ subscribers<\/h2>\n<h3 id=\"restricted-story-description\">Unlock this article \u2014 plus daily coverage and analysis of the pharma industry \u2014 by subscribing to STAT+.<\/h3>\n<p class=\"restricted-content-breaker-wrapper-cta mobile\">Already have an account? Log in<\/p>\n<div class=\"restricted-content-breaker-cards\">\n<div class=\"slider-container\" aria-label=\"Subscription plan toggle\">\n\t\t\t\t\t\t<button type=\"button\" class=\"individual\" aria-pressed=\"false\">Individual plans<\/button><\/p>\n<p>\t\t\t\t\t\t<button type=\"button\" class=\"group\" aria-pressed=\"false\">Group plans<\/button>\n\t\t\t\t\t<\/div>\n<\/p><\/div>\n<p>\t\t\t\tView All Plans\n\t\t\t<\/p><\/div>\n<\/p><\/div>\n<div class=\"restricted-message-breaker\">\n<div class=\"restricted-content-wrapper\">\n<div class=\"restricted-content-message\">\n<p class=\"restricted-content-text\">\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n<p>\t\t\t\t\tSubscribe\n\t\t\t\t\t\t\t\t\t<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<p><br \/>\n<br \/><<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novo Nordisk on Tuesday said it expects sales and profits to decline this year, as the maker of Wegovy faces growing competition in the obesity market. The Danish pharma giant said it expects sales to decrease in the range of 5% to 13% in 2026, more than the 3% decrease forecasted by analysts surveyed by [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":17754,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_daextam_enable_autolinks":"","jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[2],"tags":[],"class_list":["post-17753","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/diyhaven858.wasmer.app\/wp-content\/uploads\/2026\/02\/GettyImages-2197227495-1024x576.jpg","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/posts\/17753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/comments?post=17753"}],"version-history":[{"count":0,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/posts\/17753\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/media\/17754"}],"wp:attachment":[{"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/media?parent=17753"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/categories?post=17753"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/tags?post=17753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}